BLNC
Balance Labs, Inc.
Next earnings Aug 12, 2026
$1.55
▲ 0.00%$1.55▲ +933.33%
over 1Y
L $0.15EODHDH $5.24
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+0.0%
1M+0.0%
3M+0.0%
YTD+0.0%
1Y+933.3%
Avoid
Conviction
Horizon
Medium (3–12mo)
High return on equity (940.9%); but revenue fell -97.6% YoY.
Revenue (FY2025) $6.00K · FY2025
Balance Labs, Inc. shows $6.00K in FY2025 revenue (-97.6% YoY), a -529472.1% net margin, and 940.9% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $625K | $248K | — | — | $6.00K |
| Gross profit | — | — | — | — | $6.00K |
| Operating income | $224K | -$22.8K | -$116K | -$271K | -$13.1M |
| Net income | -$797K | -$768K | -$382K | -$528K | -$31.8M |
| Diluted EPS | $0.04 | $0.04 | -$0.02 | -$0.02 | -$1.23 |
| Net margin | -127.6% | -310.4% | — | — | -529472.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$72.3M
EV / EBITDA—
EV / Sales12047.9
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-43.7%
FCF yield-0.4%
Quality & risk
ROIC (est.)—
Free cash flow-$267K
Total debt$25.0K
Net cash$334K
Altman Z-Score-240.04 distress
Piotroski F-Score3/8
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+116.2%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — late filing notice (2026-04-02). Worth a closer look.
- 10-Q Quarterly report2026-05-15
- 10-K Annual report2026-04-10
- NT 10-K Late filing notice2026-04-02
- 8-K Officer / director change2026-02-11
- 8-K Officer / director change2025-12-16
- 10-Q Quarterly report2025-11-13
- 8-K Officer / director change2025-08-29
- 10-Q Quarterly report2025-08-14
- 10-Q Quarterly report2025-05-20
Recent filings
all on EDGAR ↗10-QPeriod ending 2026-03-312026-05-15open ↗10-KPeriod ending 2025-12-312026-04-10open ↗NT 10-KPeriod ending 2025-12-312026-04-02open ↗8-KPeriod ending 2026-02-062026-02-11open ↗8-KPeriod ending 2025-12-122025-12-16open ↗10-QPeriod ending 2025-09-302025-11-13open ↗8-KPeriod ending 2025-08-252025-08-29open ↗10-QPeriod ending 2025-06-302025-08-14open ↗10-QPeriod ending 2025-03-312025-05-20open ↗NT 10-QPeriod ending 2025-03-312025-05-15open ↗10-KPeriod ending 2024-12-312025-04-15open ↗NT 10-KPeriod ending 2024-12-312025-03-31open ↗
Frequently asked
- Is Balance Labs, Inc. (BLNC) a buy?
- BLNC currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. High return on equity (940.9%); but revenue fell -97.6% YoY.
- What is Balance Labs, Inc.'s quality score?
- BLNC scores 18.941176470588236/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001632121, latest 10-Q filed 2026-05-15) · EODHD · as of 6/22/2026, 11:36:29 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.